Effects of red ginseng supplementation on menopausal symptoms and cardiovascular risk factors in postmenopausal women: A double-blind randomized controlled trial

Menopause

Volumn 19, Issue 4, 2012, Pages 461-466

  Kim, Sun Young ^a   Seo, Seok Kyo ^b   Choi, Young Mi ^b   Jeon, Young Eun ^a   Lim, Kyung Jin ^b   Cho, Sihyun ^a   Choi, Young Sik ^b   Lee, Byung Seok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Cardiovascular risk factors; Menopausal symptoms; Postmenopausal women; Red ginseng

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; ESTRADIOL; GINSENG EXTRACT; GINSENOSIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; B SCAN; CARDIOVASCULAR DISEASE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; ESTRADIOL BLOOD LEVEL; FEMALE; GINSENG; HERBAL MEDICINE; HOT FLUSH; HUMAN; INTIMA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RED GINSENG; RISK FACTOR; TREATMENT OUTCOME; TUNICA MEDIA;

BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; POSTMENOPAUSE; QUALITY OF LIFE; REFERENCE VALUES; WOMEN'S HEALTH;

EID: 84859435882     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3182325e4b     Document Type: Article

References (50)

1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-1575. (Pubitemid 28520643)
2. Kaufert P, Boggs PP, Ettinger B, Woods NF, Utian WH. Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey. Menopause 1998;5:197-202.
3. Seidl MM, Stewart DE. Alternative treatments for menopausal symptoms. Systematic review of scientific and lay literature. Can Fam Physician 1998; 44:1299-1308. (Pubitemid 128685380)
4. Dailey RK, Neale AV, Northrup J, West P, Schwartz KL. Herbal product use and menopause symptom relief in primary care patients: a MetroNet Study. J Womens Health (Larchmt) 2003;12:634-641.
5. Huntley AL, Ernst E. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 2003;10:465-476.
6. Reed SD, Newton KM, LaCroix AX, et al. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause 2008;15:51-58.
7. Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician 2003;68:1539-1542. (Pubitemid 37296048)
8. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-1693. (Pubitemid 29505408)
9. Blumenthal M. Asian ginseng: potential therapeutic uses. Adv Nurse Pract 2001;9:26-28, 33.
10. Joo IW, Sung KH, Park JM, Lew JH, Oh HJ. Effect of Korean red ginseng on blood pressure and aortic vascular (endothelial) histological changes in rats. J Ginseng Res 2008;32:324-331.
11. Lee YJ, Jin YR, Lim WC, et al. Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells. Arch Pharm Res 2003;26: 58-63.
12. Cho JY, Park WK, Lee SK, Ahn WS, Lee YJ. Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-> and-A, independent of ligand binding. J Clin Endocrinol Metab 2004;89:3510-3515.
13. Ogita S, Sanugawa K. Clinical effectiveness of Korea ginseng on patients with climacteric disturbances. Ginseng Rev 1994;18:95-97.
14. Tode T, Kikuchi Y, Hirata J, Kita T, Nakata H, Nagata I. Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes. Int J Gynaecol Obstet 1999;67:169-174.
15. Kupperman HS, Blatt MH, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab 1953;13:688-703.
16. Kaari C, Haidar MA, Júnior JM, et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 2006;53:49-58. (Pubitemid 41736059)
17. Schneider HP, Heinemann LA, Rosemeier HP, Potthoff P, Behre HM. The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric 2000;3:50-58. (Pubitemid 30354484)
18. Heinemann LA, DoMinh T, Strelow F, Gerbsch S, Schnitker J, Schneider HP. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes 2004;2:67.
19. Erin EK, Kristine EE, Roderick M, Timothy JW. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004;104:824-836.
20. Boker LK, Van der Schouw YT, De Kleijn MJ, Jacques PF, Grobbee DE, Peeters PH. Intake of dietary phytoestrogens by Dutch women. J Nutr 2002;132:1319-1328. (Pubitemid 34606471)
21. Viereck V, Emons G, Wuttke W. Black cohosh: just another phytoestrogen? Trends Endocrinol Metab 2005;16:214-221. (Pubitemid 40853884)
22. Uebelhack R, Blohmer JU, Graubaum HJ, Busch R, Gruenwald J, Wernecke KD. Black cohosh and St. John's wort for climacteric complaints: a randomized trial. Obstet Gynecol 2006;107:247-255.
23. Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Int J Clin Pharmacol Res 1999;19:89-99. (Pubitemid 30162680)
24. Amato P, Christophe S, Mellon PL. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 2002;9: 145-150. (Pubitemid 34194110)
25. Lee Y, Jin Y, Lim W, et al. A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J Steroid Biochem Mol Biol 2003;84:463-468. (Pubitemid 36555768)
26. Fahim MS, Fahim Z, Harman JM, Clevenger TE, Mullins W, Hafez ES. Effect of Panax ginseng on testosterone level and prostate in male rats. Arch Androl 1982;8:261-263. (Pubitemid 12057162)
27. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613. (Pubitemid 28502636)
28. Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein(a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 2001;75:898-915. (Pubitemid 32401667)
29. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
30. Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 2001;73:225-231. (Pubitemid 32109850)
31. Jenkins DJ, Kendall CW, Garsetti M, et al. Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity: a controlled crossover trial. Metabolism 2000;49:537-543. (Pubitemid 30196584)
32. Chung DJ, Kim HY, Park KH, et al. Black cohosh and St. John's wort (GYNO-Plus) for climacteric symptoms. Yonsei Med J 2007;48: 289-294.
33. Jin YR, Yu JY, Lee JJ, et al. Antithrombotic and antiplatelet activities of Korean red ginseng extract. Basic Clin Pharmacol Toxicol 2007;100: 170-175.
34. Inoue M, Wu CZ, Dou DQ, Chen YJ, Ogihara Y. Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals. Phytomedicine 1999;6:257-265. (Pubitemid 129633199)
35. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 1996;23:728-732. (Pubitemid 26373922)
36. Park KH, Shin HJ, Song YB, et al. Possible role of ginsenoside Rb1 on regulation of rat liver triglycerides. Biol Pharm Bull 2002;25:457-460.
37. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979. (Pubitemid 27152782)
38. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-428. (Pubitemid 28090212)
39. Roivainen M, Viik-Kajander M, Palosuo T, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000;101: 252-257. (Pubitemid 30054151)
40. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-1397. (Pubitemid 38419992)
41. Bots ML. Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr Med Res Opin 2006; 22:2181-2190. (Pubitemid 44789983)
42. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-1437. (Pubitemid 27375333)
43. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-494. (Pubitemid 27391409)
44. Cushman M, Legault C, Barrett-Connor E, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999;100: 717-722. (Pubitemid 29383641)
45. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999;100:713-716. (Pubitemid 29383640)
46. van Baal WM, Kenemans P, van der Mooren MJ, Kessel H, Emeis JJ, Stehouwer CD. Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women. Thromb Haemost 1999;81:925-928. (Pubitemid 29312709)
47. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004;93:1238-1242. (Pubitemid 38595677)
48. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-2135.
49. Dietrich T, Garcia RI, de Pablo P, Schulze PC, Hoffmann K. The effects of cigarette smoking on C-reactive protein concentrations in men and women and its modification by exogenous oral hormones in women. Eur J Cardiovasc Prev Rehabil 2007;14:694-700. (Pubitemid 47556408)
50. Elena J, Alexandra J, Andre G, et al. Effects of Korean red ginseng (Panax ginseng C.A. Mayer) and its isolated ginsenodises and polysaccharides on arterial stiffness in healthy individuals. Am J Hypertens 2010;23:469-472.